TY - JOUR
T1 - DNA synthesis-dependent relief of repression of transcription from the adenovirus type 2 IVa2 promoter by a cellular protein
AU - Huang, Wenying
AU - Kiefer, J.
AU - Whalen, D.
AU - Flint, S. J.
N1 - Funding Information:
We thank Norma Caputo for preparation of the manuscript. This work was supported by a grant from the National Institute of General Medical Science, National Institutes of Health.
PY - 2003/9/15
Y1 - 2003/9/15
N2 - The promoter of the human adenovirus type 2 IVa2 gene, which becomes active only during the late phase of infection, is built largely from sequences spanning, and downstream of, the sites of initiation of transcription. These sequences comprise an initiator, an intragenic sequence necessary for efficient transcription from the promoter by RNA polymerase II, and an intragenic binding site for a cellular repressor of IVa2 transcription. The properties of the latter protein, which is termed IVa 2-RF, suggested that it might account for the viral DNA synthesis-dependent activation of IVa2 transcription during the adenoviral productive cycle. Here we report the results of experiments to assess the contributions of DNA template concentration and IVa2-RF binding to the activity of the IVa2 promoter using a transient expression system. When a IVa2-EGFP reporter gene was introduced into HeLa cells, in which IVa2-RF was identified, no EFGP synthesis could be detected. In contrast, in IVa2-RF-containing cells in which the plasmid carrying the chimeric gene replicated, synthesis of both the EGFP protein and the IVa2-EGFP mRNA was readily detected. A vector mutation that blocked plasmid replication reduced IVa2 promoter activity to undetectable levels. In contrast, a IVa2 promoter substitution that impaired binding of IVa2-RF increased IVa 2 promoter activity under all conditions examined. Furthermore, introduction of DNA containing the IV-RF binding site with the chimeric reporter genes resulted in increased transcription from the IVa2 promoter in the absence of plasmid replication. These properties are consistent with the hypothesis that the relative concentration of the IVa2 promoter and of the cellular repressor that binds to it governs transcription from this adenoviral promoter.
AB - The promoter of the human adenovirus type 2 IVa2 gene, which becomes active only during the late phase of infection, is built largely from sequences spanning, and downstream of, the sites of initiation of transcription. These sequences comprise an initiator, an intragenic sequence necessary for efficient transcription from the promoter by RNA polymerase II, and an intragenic binding site for a cellular repressor of IVa2 transcription. The properties of the latter protein, which is termed IVa 2-RF, suggested that it might account for the viral DNA synthesis-dependent activation of IVa2 transcription during the adenoviral productive cycle. Here we report the results of experiments to assess the contributions of DNA template concentration and IVa2-RF binding to the activity of the IVa2 promoter using a transient expression system. When a IVa2-EGFP reporter gene was introduced into HeLa cells, in which IVa2-RF was identified, no EFGP synthesis could be detected. In contrast, in IVa2-RF-containing cells in which the plasmid carrying the chimeric gene replicated, synthesis of both the EGFP protein and the IVa2-EGFP mRNA was readily detected. A vector mutation that blocked plasmid replication reduced IVa2 promoter activity to undetectable levels. In contrast, a IVa2 promoter substitution that impaired binding of IVa2-RF increased IVa 2 promoter activity under all conditions examined. Furthermore, introduction of DNA containing the IV-RF binding site with the chimeric reporter genes resulted in increased transcription from the IVa2 promoter in the absence of plasmid replication. These properties are consistent with the hypothesis that the relative concentration of the IVa2 promoter and of the cellular repressor that binds to it governs transcription from this adenoviral promoter.
UR - http://www.scopus.com/inward/record.url?scp=0141792096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141792096&partnerID=8YFLogxK
U2 - 10.1016/S0042-6822(03)00431-8
DO - 10.1016/S0042-6822(03)00431-8
M3 - Article
C2 - 14517091
AN - SCOPUS:0141792096
SN - 0042-6822
VL - 314
SP - 394
EP - 402
JO - Virology
JF - Virology
IS - 1
ER -